PLAT and liver disorder: In addition to the procoagulant balance, patients with advanced liver disease show a prevalence for hyperfibrinolysis with low levels of α2-antiplasmin inhibitor and decreased hepatic clearance of tissue plasminogen activator [53]; however, its clinical relevance has been disputed and it is not clear whether changes are directly induced by liver disease or secondary to clotting activation [56].